Advertisement

Latest News

CORALreef Extension: Enlicitide Sustains LDL-C Reductions in Interim Analysis of OLE

1 hour ago

Christie Ballantyne, MD, discusses 104-week data from this 3-year extension, noting enlicitide’s sustained effects on LDL-C, non-HDL-C, apoB, and Lp(a).

Monthly PVX108 Raises Peanut Tolerance in Children, With Brian Vickery, MD

23 hours ago

Children receiving 50 nmol PVX108 increased their tolerated peanut dose 2.4-fold, with no treatment-related anaphylaxis in the phase 2 trial.

SUMMIT Substudy Reveals Tirzepatide’s Impact on LV, Atrial Metrics of HFpEF

November 20, 2026

Christopher Kramer, MD, discusses his substudy of SUMMIT, which utilized CMR imaging to evaluate further heart health metrics versus standard imaging.

Silent Mucus Plugs in COPD and Exacerbation Risk, With Emily Wan, MD, MPH

November 20, 2026

Silent mucus plugs may flag patients with COPD at greater risk of exacerbations and death, though how to manage them remains unclear.

Viaskin Peanut Patch Shifts Peanut Allergy Biomarkers in VITESSE

November 20, 2026

In VITESSE, peanut-specific IgG4 rose about 5-fold in children aged 4 to 7 years, David Fleischer, MD, told HCPLive at ACAAI 2026.

Advertisement
Advertisement